Screener
Acurx Pharmaceuticals, Inc. ACXP Q3 2025 earnings
Reported November 12, 2025 · Before market open
EPS-$1.23Beat by $0.38
EPS estimate-$1.61
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.45
Versus estimates
Diluted EPS
FAQ
- When did Acurx Pharmaceuticals, Inc. report Q3 2025 earnings?
- Acurx Pharmaceuticals, Inc. (ACXP) reported Q3 2025 earnings on November 12, 2025 before market open.
- What were Acurx Pharmaceuticals, Inc.'s Q3 2025 revenue and EPS?
- Acurx Pharmaceuticals, Inc. reported eps of $-1.23 for Q3 2025.
- Did Acurx Pharmaceuticals, Inc. beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-1.61 by $0.38.
- How did Acurx Pharmaceuticals, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 623.5% from $-0.17.
- Where can I find Acurx Pharmaceuticals, Inc.'s Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001104659-25-109698) directly on SEC EDGAR. The filing index links above go to sec.gov.
